NEWR

New Relic reported the results of its Q4 on Tuesday afternoon. The results themselves were quite satisfactory with revenue growth of 34%, and EPS of $.13. These results represented beats of about 3% on revenues and $.07/share on EPS. The EPS beat was entirely a function of the revenue beat-essentially all of the extra revenue…

To access this post, you must subscribe.

Read More

Cognizant (CTSH) We are buying 200 shares of Cognizant (CTSH) in our income/stability portfolio, using up our cash balance, and a little more. We are buying the shares at a price of $64.63, the closing price on Monday, which will take $12,926. We had sold Cognizant shares back in August at $75/share in the wake…

To access this post, you must subscribe.

Read More

I imagine that all of our subscribers are aware that the Fed chose to raise rates this afternoon. That decision had been anticipated by most market participants. The Fed statement, however, was considered to be more aggressive with regards to the likelihood of future rate hikes than might have been hoped. The Fed also continued…

To access this post, you must subscribe.

Read More

I will try to make this as short as possible and long as necessary. Some subscribers like my efforts in terms of diction; all subscribers are going to like it better if I can produce profitable picks. I think the recent crash is epochal in nature. I have seen my share of crashes such as…

To access this post, you must subscribe.

Read More

We are selling our position in Veeva shares in our model portfolio at Friday’s closing price of $108.87 Our position was 201 shares which we acquired at a price of $58 about a year ago. The sale will net us about $21,900. We are not selling the shares because of any concern about the quarter.…

To access this post, you must subscribe.

Read More